ArticleVirchows Archiv : an international journal of pathology2026
Immunohistochemical characterization of the tumor immune microenvironment in laryngeal premalignancy: insights into early immune alterations in carcinogenesis.
Article in Virchows Archiv : an international journal of pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Laryngeal squamous cell carcinoma (LSCC) frequently arises from premalignant dysplastic lesions, yet reliable predictors of malignant transformation remain limited. This study investigates the immune microenvironment of laryngeal dysplasia and its association with progression to invasive carcinoma. We conducted a retrospective cohort study of 110 patients with histologically confirmed laryngeal dysplasia excised between 2009 and 2022, reclassified according to the 2022 WHO two‑tier system. Clinical data, including tobacco and alcohol exposure, were collected, and outcomes included recurrence, progression to invasive carcinoma, and cancer‑free survival. Immunohistochemistry and digital image analysis were used to quantify intraepithelial and stromal immune markers (CD3+, CD4+, CD8+, CD68+, CD163+, PD-L1). High-grade dysplasia represented 68% of cases, and 33% progressed to invasive carcinoma. Intraepithelial T-cell and macrophage densities did not differ significantly between progressing and non-progressing lesions, whereas stromal immune characteristics showed prognostic value. In multivariate analysis, alcohol exposure, dysplasia grade, stromal CD8 + density, and PD-L1 expression were independently associated with progression. Former drinkers showed a higher risk than lifelong abstainers, while high-grade dysplasia carried a fourfold increased risk relative to low-grade lesions. Higher stromal CD8 + infiltration and lower stromal PD-L1 expression correlated with progression, though with modest effect sizes. Digital immune profiling validated distinct stromal immune signatures associated with progression in laryngeal dysplasia. These findings suggest that malignant transformation depends not only on histological grade and alcohol exposure but also on subtle immune alterations, supporting integration of stromal immune markers with WHO grading to refine risk stratification and guide surveillance strategies.
Indexed as
Identifiers
42283829What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.